Cytoplasmic TRAIL-R1 is a positive prognostic marker in PDAC

BACKGROUND: The death receptors TRAIL-R1 and TRAIL-R2 are frequently overexpressed in cancer and there is an emerging evidence for their important role in malignant progression, also in the case of pancreatic ductal adenocarcinoma (PDAC). In their canonical localization at the plasma membrane, TRAIL...

Descripción completa

Detalles Bibliográficos
Autores principales: Gundlach, Jan-Paul, Hauser, Charlotte, Schlegel, Franka Maria, Böger, Christine, Röder, Christian, Röcken, Christoph, Becker, Thomas, Egberts, Jan-Hendrik, Kalthoff, Holger, Trauzold, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6069838/
https://www.ncbi.nlm.nih.gov/pubmed/30064384
http://dx.doi.org/10.1186/s12885-018-4688-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6069838/
https://www.ncbi.nlm.nih.gov/pubmed/30064384
http://dx.doi.org/10.1186/s12885-018-4688-8

Ejemplares similares